Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Michael

Psychiatry Chicago, IL Doctor of Osteopathy

NPI 1518300375 CMS profile 3966190

2334 W Lawrence Ave Ste 221, Chicago, IL 60625

Open in the dashboard

General payments

$4,587

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Michael of Chicago, IL is reported in the CMS Open Payments database as having received $4,587 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $47 2
2024 General $246 8
2023 General $385 17
2022 General $2,126 28
2021 General $577 4
2020 General $290 17
2019 General $916 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Michael
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to David Michael were reported at $47. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year David Michael Psychiatry median Middle half National median
2019 $916 $184 $59–$605 $163
2020 $290 $119 $36–$372 $114
2021 $577 $143 $43–$576 $132
2022 $2,126 $153 $50–$590 $149
2023 $385 $170 $56–$651 $160
2024 $246 $179 $57–$673 $164
2025 $47 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Brainsway USA Inc $1,747 2 payments
  2. Supernus Pharmaceuticals, Inc. $600 5 payments
  3. AbbVie, Inc. $582 33 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $498 31 payments
  5. ITI, Inc. $478 19 payments
  6. Janssen Pharmaceuticals, Inc $302 12 payments
  7. Neos Therapeutics, LP $65 4 payments
  8. Otsuka America Pharmaceutical, Inc. $64 4 payments
  9. Shire North American Group Inc $63 3 payments
  10. Allergan Inc. $42 3 payments
  11. Other $146 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,942 117 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  3. Education $145 6 payments
Products named General payments · program years 2019–2025
  1. BrainsWay Deep TMS $1,747 2 payments
  2. VRAYLAR $582 33 payments
  3. CAPLYTA $431 17 payments
  4. Trintellix Central Nervous System (CNS) $348 22 payments
  5. SPRAVATO $263 10 payments
  6. TRINTELLIX Neuroscience $130 8 payments
  7. VYVANSE $83 4 payments
  8. INVEGA SUSTENNA $66 4 payments
  9. Adzenys XR-ODT $65 4 payments
  10. COTEMPLA XR-ODT $65 4 payments
  11. Other $424 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record